Krystal Biotech Inc (KRYS)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 818,355 | 558,450 | 626,295 | 310,844 | 209,023 |
| Total stockholders’ equity | US$ in thousands | 778,641 | 522,231 | 593,576 | 292,084 | 202,914 |
| Financial leverage ratio | 1.05 | 1.07 | 1.06 | 1.06 | 1.03 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $818,355K ÷ $778,641K
= 1.05
The financial leverage ratio of Krystal Biotech Inc has displayed a relatively stable trend over the past five years, hovering around an average of approximately 1.05 to 1.07. This ratio indicates that the company's capital structure is primarily financed through a combination of debt and equity, with a slightly higher reliance on debt.
The consistent nature of the financial leverage ratio suggests that Krystal Biotech has maintained a balanced approach to funding its operations and investments. However, it is important to note that a higher financial leverage ratio may indicate higher financial risk, as increased leverage can amplify both returns and losses.
Overall, the stability of Krystal Biotech's financial leverage ratio indicates that the company has been managing its debt and equity levels effectively to support its growth and operations in a sustainable manner.
Peer comparison
Dec 31, 2023